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ABSTRACT  
Tff3 peptide exerts important functions in cytoprotection and restitution of the gastrointestinal 
(GI) tract epithelia. Moreover, its presence in the rodent inner ear and involvement in the hearing 
process was demonstrated recently. However, its role in the auditory system still remains elusive. 
Our previous results showed a deterioration of hearing with age (presbyacusis) in Tff3 deficient 
animals. Present detailed analysis of auditory brain stem response (ABR) measurements and an 
immunohistochemical study of selected functional proteins indicated a normal function and 
phenotype of the cochlea in Tff3 mutants. However, a microarray-based screen using tissue 
derived from the auditory central nervous system revealed an alteration of securin (Pttg1) and 
serpina3n expression between wild-type and Tff3 knock-out animals. This was confirmed by qRT-
PCR. We found highly down-regulated Pttg1 and up-regulated serpina3n expression as a 
consequence of genetically deleting Tff3 in mice, indicating a potential role of these factors during 
the development of presbyacusis. 
 
Key words: Trefoil peptides, cochlea, inferior colliculus, presbyacusis, expression patterns 
 
Non-standard abbreviations:  
Auditory brain stem responses (ABR), gastrointestinal (GI), human antychymotrypsin (huACT), 
murine antychymotrypsin (muACT), inferior colliculus (IC), inflammatory bowel disease (IBD), inner 
hair cell (IHC), outer hair cell (OHC), phosphoinositide 3-kinases (PI3K), protein inhibitor 6 (PI-6), 
serin peptidase inhibitors (SPIs), stria vascularis (SV), trefoil factor family (TFF) 
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INTRODUCTION 
The trefoil factor family (TFF) in mammals comprises three peptides: TFF1, 2, and 3, 
predominantly expressed in the gastrointestinal (GI) mucosa but also in several other tissues [1-3]. 
TFFs play an important physiological role and are up-regulated in many pathological conditions of 
mucosal injury such as inflammatory bowel disease (IBD), gastric and duodenal ulcers [4]. TFF3 
maintains the GI integrity [5], promotes intestinal epithelial wound healing [6] and modulates 
adhesion, migration and survival of epithelial cells [7]. Moreover, Tff3 synthesis was shown in the 
rat and human hypothalamus [8]. The presence of Tff3 exclusively in oxytocinergic neurons but not 
in vasopressinergic neurons suggested its role as neuropeptide acting together with oxytocin along 
the hypothalamo-pituitary axis [9]. 
Previously, we demonstrated a new expression pattern of Tff3 in the rodent cochlea and the 
peptide's involvement in the hearing process [18]. We showed that Tff3 knock-out mice display a 
deterioration of hearing with age, a feature characteristic for presbyacusis (age related hearing 
loss) [11, 12]. However, in Tff3 deficient animals we did not observe any degeneration of cochlear 
hair cells and spiral ganglion neurons or atrophy of the stria vascularis (SV) [10].  
Presently, we focused our analysis on auditory brain stem responses (ABR) and spatial and 
temporal expression of particular marker proteins involved in normal hearing comparing Tff3 
knock-out to wild-type animals. By studying ABR responses we investigated if the auditory 
processing pathway is obstructed in Tff3 knock-out animals, whereas examination of different 
cochlear protein markers may reveal if lack of Tff3 affects expression of particular genes in the 
cochlea. Lack of striking differences in the cochlea using these assays together with interesting 
data about functional changes underlying age-related hearing loss in the inferior colliculus (IC) [13, 
14] turned our attention to the auditory central nervous system (CNS). We thus performed a 
microarray-based expression screening of genes differentially expressed in the IC followed by 
confirmation using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR). Two 
conspicuous candidate sequences showed significantly altered expression levels. Neither the 
presence of Pttg1 and serpina3n in the auditory system nor their interplay with trefoil peptides has 
been noted so far. Therefore, the differential expression pattern of these genes caused by genetic 
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deletion of Tff3 suggests their potential involvement during presbyacusis which requires additional 
elucidation of the mechanisms involved. 
 
MATERIALS AND METHODS 
Animals 
Tff3-deficient animals [5] were obtained from Prof. D.K. Podolsky (Harvard Medical School). 
These animals were backcrossed to C57BL/6 and to 129/Sv mice and maintained on a mixed 
background. Tff3 homozygous sister lines were established representing a Tff3 deficient (Tff3-/-) 
and a wild-type genotype (Tff3+/+), respectively. Animal experiments were approved and complied 
with all requirements at the University of Tübingen and the German law for use and welfare of 
laboratory animals (Tierschutzgesetz). Animal studies are also in line with the ’Ethical principles 
and guidelines for scientific experiments on animals’ of the Swiss Academy of Medical Sciences. 
All efforts were made to minimize the number of animals used and their suffering. Animals were 
killed by decapitation following anesthesia with carbon dioxide and cochleae were removed 
according to national ethical guidelines.  
 
ABR responses 
A minimum of three wild-type and Tff3-/- mutants were used for each measurement. All 
measurements were made under anesthesia. A dosage of 50 mg/kg ketamin hydrochloride 
(Ketamin 50 Curamed, CuraMED Pharma, Germany), 8 mg/kg xylazin hydrochloride (Rompun 
290, Bayer Leverkusen, Germany) and 0.25 mg/kg atropin sulfate (Atropinsulfat, Braun, Germany) 
was used. The mixture was applied intraperitoneally. Depth of anesthesia was checked every 30 
minutes by testing the pedal withdrawal reflex. If necessary, additional injections of about 50% of 
the initial dose were given. Body temperature was maintained at 37°C using a heating pad and 
thermo resistor placed under the animals’ body.  
ABR recordings were performed in a sound proof chamber (IAC, Niederkrüchten, Germany). 
For stimulus generation and recording of responses, a multi-function IO-Card (PCI-6259, National 
Instruments, Austin TX, USA) was used, housed in an IBM compatible computer. Sound pressure 
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level was controlled with an attenuator (custom-made) and amplifier. Stimuli were delivered to the 
ear in a calibrated open system by a loudspeaker (DT911, Beyerdynamics, Heilbronn, Germany) 
placed 3 cm lateral to the animals’ pinna. Sound pressure was calibrated on-line prior to each 
measurement with a microphone probe system (Brüel & Kjaer 4191, Bremen, Germany) placed 
near the animals’ ear. Recorded signals were amplified (100 dB total amplification) and bandpass 
filtered (0.2-5 kHz). Clicks of 100 µs duration or tone pipes of 3 ms duration (including 1 ms rise 
and fall time) were presented. To record bioelectrical responses, subdermal silver-wire electrodes 
were inserted at the vertex (active) and ventro-lateral (reference) to the measured ear. Electrical 
signals were averaged over 64 repetitions of stimulus pairs with alternating phase. ABRs were 
measured for clicks or stimulus frequencies between 2.0 and 45.2 kHz and sound pressure levels 
from 20 up to 110 dB SPL in 5 dB steps. To construct the ABR-input-output functions the peak to 
peak amplitudes of the ABR waveforms at the different sound pressure levels were determined. 
Thresholds were defined as the sound pressure level where a stimulus-correlated response was 
clearly identified by visual inspection of the averaged signal.  
 
Tissue preparation 
Wild-type and Tff3 knock-out mice were decapitated following anesthesia with carbon dioxide. 
The bullae were removed and the cochlear spiral was dissected in Hanks’ Balanced Salt Solution 
(HBSS: KCl 5.36, MgSO4*7H2O 0.405, MgCl2*5H2O 0.491, NaCl 141, HEPES 9.98, L-glutamin 
3.42, CaCl2*2H2O 1.56, D-glucose 6.30; concentration of all components in mMol/L) with a pH of 
7.4. Cochleae were fixed by immersion in 2% paraformaldehyde (SIGMA, Munich, Germany; all 
chemicals from SIGMA, unless indicated otherwise), 125 mM sucrose in 100 mM phosphate 
buffered saline (PBS), pH 7.4, for 2 hours. Cochleae of animals older than postnatal day 10 were 
decalcified after fixation for 15 min to 2 h in rapid bone decalcifier (Eurobio, Fischer-Scientific, 
61130 Nidderau, Germany). After overnight incubation in 25% sucrose in PBS, pH 7.4, cochleae 
were embedded in O.C.T. compound (Miles Laboratories, Elkhart, IN, USA), cryosectioned at 10 
µm, mounted on SuperFrost*/plus microscope slides, dried for 1 hour, and stored at -20ºC before 
use. For the detection of securin protein in brain sections, brains were removed and fixed for 48 h 
in 4% paraformaldehyde, embedded in 4% agarose, and stored in PBS + 0.4% paraformaldehyde 
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at 4°C. The tissue was sectioned at 60 µm with the VT 1000S vibrating microtome (Leica, Wetzlar, 
Germany). Slices were kept in PBS in a 24-well plate. 
 
Fluorescence immunohistochemistry of different markers 
For immunohistochemistry, mouse cochlea sections were stained and imaged as described [15, 
16]. The following antibodies were used: goat polyclonal anti-KCNQ4 (Santa Cruz Biotechnology, 
CA, USA, sc-9385, Lot B161), goat polyclonal anti-megalin (Santa Cruz Biotechnology, Lot 
D0914), rabbit polyclonal anti-KCNQ1 (Santa Cruz Biotechnology, sc-20816, Lot B2103), sheep 
polyclonal anti-neurofilament 200 (NF200, The Binding Site, Heidelberg, Germany, PH510), rabbit 
polyclonal anti Kir4.1 (Alomone Labs, Jerusalem, Israel, APC-035), rabbit polyclonal anti-otoferlin 
[17], goat polyclonal anti-synaptophysin (Santa Cruz Biotechnology, sc-7568, Lot E2308), rabbit 
polyclonal anti-securin (Abcam, ab26273), goat polyclonal anti-serpina3n (R&D, AF4709, Lot 
CBKW01) and rabbit polyclonal anti-Tff3 [18]. To detect prestin, a polyclonal rabbit antibody 
directed against the C-terminal epitope of a rat prestin was used [19]. Primary antisera were 
detected with fluorescently labeled secondary IgG antibodies (Cy3-conjugated antibodies, Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA, or Alexa Fluor-488 conjugated antibodies, 
Molecular Probes, Eugene, OR, USA). Sections were embedded with Vectashield mounting 
medium with 4',6-diamidino-2-phenylindole (DAPI), staining cell nuclei in blue (Vector Laboratories, 
Burlingame, CA, USA). Specimens were imaged using an Olympus AX-70 microscope equipped 
with epifluorescence illumination and 40x (numerical aperture 1.0) or 100x oil immersion objectives 
(numerical aperture 1.35). Images were acquired using a CCD color view 12 camera and imaging 
system Analysis (SIS, Münster, Germany) and additionally processed with Adobe Photoshop 6.0. 
Immunohistochemical comparison between control and Tff3 knock-out mice were all performed 
using the same antibody titre for wild-type and mutant mice and identical exposure times were 
used when comparative photographs were taken. Immunohistological analyses were performed 
from cochlea samples taken from three to five Tff3 knock-out and wild-type mice. Representative 
images were chosen for presentation. 
For localization of securin protein in the IC, brain sections of wild-type mice were prepared as 
described above. For protein detection on these slices, sections were washed briefly in PBS 
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containing 0.05% Tween 20 and endogenous peroxidases were blocked in 3% H2O2. Blocking of 
streptavidin-biotin was carried out using the streptavidin-biotin blocking kit (Vector Laboratories) 
according to the manufacturer’s instructions. Sections were incubated over night at 4°C with the 
primary securin antibody (Abcam, ab26273). Following incubation with the secondary antibody 
(biotinylated goat anti-rabbit, Vector Labs, Burlingame, CA, USA), the sections were washed in 
PBS, and the chromogenic detection was carried out (3-amino-9-ethylcarbazole, AEC). Nuclei 
were counterstained with methyl-green (Vector Laboratories) and viewed using an Olympus AX70 
microscope. Alternatively, securin protein and Arg3.1 mRNA, as a marker of excitatory 
glutamatergic neurons, was co-detected using a newly developed method described in [20].  
 
Western blot analysis 
For Western blot analysis, cochlear tissue of control and Tff3−/− mice were homogenized and 
lysed in CelLytic MT Tissue Lysis/Extraction Reagent (Sigma-Aldrich C3228) supplemented with a 
protease inhibitor cocktail (1:50, Sigma-Aldrich P8340). Nuclei and cell debris were pelleted by 
low-speed centrifugation at 280 g for 5 min at 4°C and the supernatant was used for Western 
blotting. Protein contents were determined by using the Bradford method. SDS-PAGE and Western 
blotting were carried out using the XCell II SureLockTM Mini-Cell and XCell II Blot Module from 
Invitrogen. 35 µg protein lysate per lane of each cochlear or IC sample was loaded on a 4-12% 
Tris-glycine gel (Invitrogen), resolved and transferred onto PVDF membrane (Invitrogen) according 
to the manufacturer’s instructions. Blotted proteins were incubated with rabbit polyclonal anti-
securin antibody (1:750, Abcam ab26273) together with mouse monoclonal anti-ezrin antibody (0.5 
µg/ml, Dianova DLN-10378) as a housekeeping protein, to ensure loading of equal amount of 
proteins, followed by ECLTM peroxidase labeled anti-rabbit or anti-mouse antibodies, respectively 
(1:2000, GE Healthcare). Labeled proteins were detected by chemiluminescence using ECL Plus 
Western Blotting Detection Reagents (GE Healthcare). 
 
Chip hybridization 
RNA was isolated from IC of 12-month-old mice using the RNA NOW kit (Biogentex, Seabrook, 
TX). Two independent RNA samples were obtained from wild-type and Tff3 knock-out mice. RNA 
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preparation, hybridization to oligonucleotide arrays (Set 430A and 430B) and scanning of the 
arrays were performed as described in the Affymetrix GeneChip Expression Analysis Manual 
(http://www.affymetrix.com). Scanned files were analyzed with GeneChip (Affymetrix, Santa Clara, 
CA) and the expression data were saved as an Excel file containing expression values (Average 
Difference). 
 
Quantitative RT-PCR 
For qRT-PCR, 3-4 independent RNA samples were extracted from the adult IC and the cochlea 
at postnatal day 10 (P10), and at 4 and 14 weeks. The IC was identified in accordance with the 
mouse atlas of Franklin and Paxinos [21]. For RNA preparation, tissue was dissected with small 
forceps and immediately frozen in liquid nitrogen and stored at -70°C before use. 2 µg of RNA was 
reverse transcribed with the Transcriptor First Strand cDNA Synthesis Kit (Roche, Basel, 
Switzerland). Quantitative gene expression analysis was performed on a Lightcycler 480 II (Roche) 
using SYBR Green. The following primers were used (all sequences from Mus musculus): Gapdh 
(Genebank accession Nr. NM_008084): forward 5’- TCCTGCACCACCAACTGCTT-3’, reverse 5’- 
GTGGCAGTGATGGCATGGAC-3’, Rpgrip1 (NM_023879): fw 5’- TGTCACATGCAGAGACCACA-
3’, rev 5’- ATGCGGCTGTTCTTGAAGTC-3’, Pttg1 (NM_013917): fw 5’-
GGCATCTAAGGATGGGTTGA-3’, rev 5’- CATAGGCTTTTCGGCAACTC-3’, Prl (NM_011164): fw 
5’-CCACTTCTTCCCTGGCTACA-3’, rev 5’-GATGTATTCGGGGGCTTCTT, Qk (NM_021881): fw 
5’-GCAGCTGATGAACGACAAGA-3’, rev. 5’-CGTCAGGCAATTCTGCACTT-3’, Serpina3n 
(NM_009252): fw 5’-AGGACATTGATGGTGCTGGT-3’, rev 5’-TAGGGTGTGGTCAGGTCCTC-3’, 
Kcnj9 (NM_008429): fw 5’- CCTCGAGAGGGACGACTTC-5’, rev 5’- 
CTCAAAGGTTTCGTGGAAGC-3’, Cap1 (NM_007598): fw 5’- CTGGAAGGCAAGAAATGGAG -3’, 
rev 5’- ACCAGGCCAAGCTTCTTACA-3’, Tnfrsf12a (NM_013749): fw 5’- 
TTGGCGCTGGTTTCTAGTTT -3’, rev 5’- GAATGAATGGACGACGAGTG -3’. The cycling 
condition comprised 10 min of preincubation at 95oC followed by 40 cycles at 95oC for 15 sec and 
60oC for 1 min. All primers were validated for their amplification efficiency. Each sample was 
analyzed in triplicate and data were analyzed with the 2-∆∆Ct method. 
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RESULTS 
Hearing measurement 
To investigate if auditory processing in Tff3 knock-out animals is obstructed, a detailed study of 
ABR-thresholds and amplitudes was performed by analyzing the animals’ responses to clicks and 
pure tone bursts. Figure 1 presents averaged ABR-threshold losses of wild-type and Tff3 knock-out 
mice at different ages, as a reference the average audiogram of P23 wild-type mice were used. In 
wild-type mice threshold loss was observed at all ages beyond P23, increasing from low to high 
frequencies at any age. This corresponds to the normal threshold loss pattern seen in mice 
showing accelerated presbyacusis [22]. In knockout-mice a conspicuous threshold loss in the low-
frequency was range observed even in the youngest animals measured. With increasing age the 
threshold loss increased to values up to 45-50 dB loss in the frequency range above 20 kHz. 
Compared to the wild-type mice, at 11 and 15 months the increased pan-cochlear threshold loss of 
approximately 20 dB in the knockout mice was statistically significant (p <0.05; t-test) at any 
frequency. The analysis of the ABR-waveforms, corrected for elevated thresholds in the knockout 
mice, showed no alterations in latency or amplitudes (data not shown).  
 
Immunohistochemical analysis of the cochlea of Tff3 mutants 
Tff3 knock-out mice developed hearing loss progressing with age. Expression of Tff3 in the 
organ of Corti, including in hair cells and supporting cells has been described previously [10, 18]. 
However, our previous preliminary study revealed no gross morphological abnormalities in the 
cochlea of Tff3 mutant animals [10]. Therefore we now performed a detailed study in adult wild-
type and Tff3 deficient mice and surveyed the distribution of a series of key proteins related with 
auditory function.   
The Ca2+ binding protein otoferlin, which resides in synaptic vesicle membranes, showed a 
normal expression pattern in Tff3-deficient animals as well as the neurofilament subunit 200 
(NF200) which is a marker for afferent fibers (Fig. 2A). Moreover, outer hair cell-specific markers, 
such as the voltage-gated potassium channel KCNQ4 was detected at the basal pole of OHCs 
(Fig. 2B) and  the OHC motor protein prestin  was present in low-frequency (apical/medial) and 
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high-frequency (midbasal/basal) cochlear turns (Fig. 2C). Expression of KCNJ10, the inwardly 
rectifying potassium channel, was not changed in the organ of Corti of Tff3 knock-out mice (Fig. 
2D). Likewise, a marker for sites of synaptic transmission, synaptophysin, was present throughout 
efferent boutons in OHCs (Fig. 2E).  
Next to the already documented expression of Tff3 in the organ of Corti and spiral ganglion [10, 
18] we also observed expression in the stria vascularis (SV) and its absence in Tff3 mouse 
mutants (Fig. 3A). To examine potential defects caused by loss of Tff3 in the SV we examined 
several marker proteins expressed in this tissue. Expression of KCNJ10 was localized in the 
intermediate cells (Fig. 3B). Strong expression of the voltage-activated potassium channel KCNQ1 
and megalin, a protein that is essential for endocytosis of lipoproteins and low molecular weight 
proteins in absorptive epithelia, was observed in the apical membrane of marginal cells of the SV 
(Fig. 3C, D respectively). Thus in summary we found no evidence that loss of Tff3 affects gene 
expression in the cochlea. 
 
A microarray-based screen for Tff3-regulated genes during presbyacusis  
Since we observed no evidence for molecular changes in Tff3 mutants in the cochlea we next 
concentrated on the analysis of the central auditory system. Within the central auditory system the 
IC, the principal midbrain nucleus of the auditory pathway, has been described to undergo 
morphological and functional changes underlying age-related hearing loss [13, 14]. To identify 
potential target genes for Tff3 in the IC we used a microarray-based screen. We employed gene 
chips covering the expression of 34.000 known mouse genes and expressed sequence tags. In 
our analysis, we compared the expression profile of the IC from aged Tff3 knock-out mutants to 
wild-type controls. As a result, a list of genes showing altered expression levels in the absence of 
Tff3 was generated. We focused our study on a set of selected genes that were highly down- or 
up-regulated as presented in Table 1. These genes corresponded to: retinitis pigmentosa GTPase 
regulator interacting protein 1, (Rpgrip1; Mouse genome informatics (MGI) reference 1932134), 
pituitary-transforming gene 1 (Pttg1; (securine), MGI 1353578), prolactin (Prl; MGI 97762), quaking 
(Qk; MGI 97837), serine (or cysteine) peptidase inhibitor, clade A, member 3N (Serpina3n; MGI 
105045), potassium inwardly-rectifying channel, subfamily J, member 9 (Kcnj9; MGI 108007), 
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adenylate cyclase-associated protein 1 (Cap1; MGI 88262),) and tumor necrosis factor receptor 
superfamily, member 12a (Tnfrsf12a; MGI 1351484). 
 
Confirmation of microarray data by qRT-PCR 
We next employed qRT-PCR to confirm the differential expression of the selected genes 
independently. Total RNA from the inferior colliculi of adult mice was extracted, and served as a 
template for qRT-PCR with gene-specific primers (see methods). As a control, amplification of the 
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (Gapdh) was performed. A 
strong down-regulation of Pttg1 (securin) in the IC of Tff3 knock-out mice (Fig. 4A) was noted, 
while serpina3n was highly up-regulated compared to wild-type animals (Fig. 4C), which was 
consistent with the results from the expression chips (Table 1). In contrast, Prl, Qk, Cap1, Kcnj9 
and Tnfrsf12a failed to show a significant difference in mRNA levels between wild-type and Tff3 
knock-out animals and expression of Rpgrip1 was not detected (data now shown).  
Due to a strong regulation of expression observed for Pttg1 and serpina3n in the IC the 
question arose if these genes were also present and differentially expressed in the peripheral 
auditory system. Expression of both genes was detected in the cochlea of Tff3 wild-type mice at 
postnatal day 10 (P10), and at the age of 4 and 14 weeks by qRT-PCR (data not shown). 
Moreover, in the cochlea of adult Tff3 knock-outs as compared to wild-type animals, Pttg1 and 
serpina3n were down- or up-regulated, respectively, at a similar level as seen in the IC (Fig. 4B, D 
respectively). 
 
Expression and downregulation of securin in Tff3 mutants 
 We next were interested to confirm expression of Pttg1 (securin) and serpina3n at the protein 
level. Using commercially available antibodies raised against serpina3n we were unable to observe 
a signal using immunohistochemistry or Western blotting (data not shown). In contrast polyclonal 
antibodies raised against securin allowed us to localize immunoreactivity in both tissues. In the 
adult cochlea securin was strongly expressed in Deiter´s cells, mesenchymal tissue underlying the 
organ of Corti and in spiral ganglion neurons (Fig. 5 A). In age-matched Tff3 mutants we observed 
no immunoreactivity for securin (Fig. 5 B). To further confirm this point we performed Western blots 
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of cochlear protein lysates at P22 and 12 months (Fig. 5C). At P22 Tff3 expression appeared only 
weakly reduced in cochlear lysates of Tff3 mutants compared to wild-type animals. At 12 months 
securin expression was found to be downregulated in comparison to P22 in wild-type animals. In 
cochlear lysates of Tff3 mutants at 12 months of age no securin expression was observed. Finally, 
on sections of the inferior colliculus of adult wild-type mice immunoreactivity for securin was 
detected at 9 months of age but was absent in age-matched Tff3 mutants (Fig. 5 D and E). Taken 
together these data confirm the downregulation of securin mRNA in the cochlea and IC also at the 
protein level.  
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DISCUSSION 
Earlier studies demonstrated expression of Tff3 in the spiral ganglion and vestibular ganglion 
neurons. Moreover, in Tff3 knock-out mice a pronounced deterioration of hearing with progressing 
age was observed. Analysis of middle and inner ear morphology however, excluded existence of 
any gross abnormalities which may affect the hearing process [10].  
In the present study, we further analyzed the inner ear phenotype of Tff3 mutants by examining 
the expression of eight specific marker proteins which are important for normal hearing. When 
comparing wild-type to Tff3 knock-out animals, no difference in expression patterns of these 
proteins was noted excluding their possible contribution to the hearing defect in Tff3 knock-out 
mice. Furthermore, quantification of spiral ganglion neurons of wild-type and Tff3 knock-out mice at 
different ages (postnatal day 20 (P20), 4-month and 15-month) did not reveal any gross difference 
in their number or morphology (data not shown). Finally, analysis of data from ABR measurements 
indicated that the processing of auditory information is not hampered in the Tff3 knock-out mice. All 
these facts implied that the cause for the auditory defect may be localized at a different level.  
In the peripheral auditory system both mice and humans undergo similar changes during 
hearing loss [23]. A common type of presbyacusis occurs at high frequencies and is caused by hair 
cell degeneration at the basal end of the cochlea [24]. This peripheral hearing loss eliminates 
evoked activity in high frequency auditory nerve fibers and translates into loss of sensitivity to high 
frequencies in central auditory nuclei [25]. Loss of high frequency sensitivity at the periphery 
eliminates neural responses to high frequency simple sounds in the central auditory system. 
However, it is unclear how age-related hearing loss affects more complex neural responses such 
as spectral integration which is important for the analysis of complex sounds [26]. Multiple tuned 
and combination-sensitive neurons are found in the IC of both mustached bats [26] and mice [27]. 
Felix and Portfors (2007) found that the majority of combination-sensitive and multiple tuned 
neurons are sensitive to high frequencies which led them to suggest that response properties of 
these types of neurons will be affected by age-related high frequency hearing loss. They further 
hypothesized that high frequency hearing loss reduces spectral integration properties in the IC. 
They based their study on the examination of neural responses in the IC of CB57Bl/6 mice to 
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single and combination of tones to analyze the extent of spectral integration in the IC after age-
related high frequency hearing loss. 
When ABR-thresholds in wild-type and Tff3 knock-out mice were assessed we observed a 
deterioration of hearing in both groups over age, most pronounced in the high frequency range 
[10], a feature quite characteristic for presbyacusis [11]. However, high frequency hearing loss was 
more pronounced in the Tff3 knock-out than in the wild-type mice. The Tff3 knockout mouse thus 
shows the characteristic hallmark of presybacusis and therefore may be a useful model to identify 
genes involved during this process. Since no degeneration of hair cells, SV or spiral ganglion 
neurons in the cochlea of Tff3 deficient mice was noted [10] and no changes of molecular markers 
were observed in the cochlea (present study) we extended our investigation to the auditory CNS 
and particularly to the IC. To uncover genes related to the effect of presbyacusis, expression 
microarrays were applied. 
A highly significant change in expression of two genes in the IC and cochlea of Tff3 knock-out 
mice was observed. One of these genes, down-regulated in Tff3 deficient animals, is named 
securin (Pttg1). Pituitary tumor-transforming gene-1 (Pttg1) was isolated from rat pituitary tumor 
cells in 1997 [28] and subsequently identified as a vertebrate securin, which regulates sister-
chromatid separation [29]. Pttg1 is transcriptionally regulated by various growth factors, is highly 
expressed in most of the tumors and tumor cell lines analyzed to date and thus defined as an 
oncogene (for review see: [30]). Securin directly binds to several gene promoters and regulates 
transcriptional processes by interacting with other proteins such as p53, Sp1, c-Myc, FGF2, cyclin 
D3, p21 prolactin, and MMP2 (for review see: [31]). Up-regulation of Pttg increases cell 
proliferation and induces cellular transformation and promotes tumor development in nude mice. 
Conversely, down-regulation of Pttg in cancer results in suppression of tumor growth and 
angiogenesis, suggesting that Pttg may serve as an important target gene for the treatment of 
cancer. The molecular mechanism by which Pttg mediates its tumorigenic function is still unclear 
[30]. Pttg1 functions in cell replication [29], cell cycle control [32], DNA damage/repair [33], organ 
development, metabolism and cell transformation processes [34]. It was shown to be required for 
human fetal brain development [35] and telencephalic neurogenesis [36].  
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The second gene, serpina3n, was strongly up-regulated in Tff3 deficient animals. Serpins (serin 
peptidase inhibitors or SPIs) are the largest family of protease inhibitors and extend to all branches 
of life [37, 38]. Members of this class of protein perform roles in diverse physiological processes 
such as the blood clotting cascade, apoptosis, and chromatin condensation [39]. Gene expression 
studies suggest that serpina3n (also known as EB22.4 and referred to as muACT-n, murine anti-
chymotrypsin) is the closest murine orthologue of huACT (human anti-chymotrypsin). In particular, 
it is the only member of the serpina3 cluster that is expressed in the murine brain under resting 
conditions [40], consistent with evidence that huACT plays a role in the inflammatory response in 
that organ. As with huACT, muACT-n shows a wide tissue distribution: it is found in the liver, brain, 
testis, lung, thymus, spleen, and to a lesser extent bone marrow, skeletal muscle, and kidney [40]. 
In the rat liver, three members of the SPI family have been cloned and characterized [41]. SPI-1 
and SPI-2 genes are expressed in normal rat liver, but SPI-3 is virtually silent in normal rats and 
only becomes transiently active during acute inflammation in the rat liver [42] and after transient 
ischemia in the rat brain [43]. Endogenous expression of SPI-3 in response to inflammatory 
stimulation was also demonstrated in specific cells of ocular tissues (epithelial cells of the iris and 
ciliary body, and astrocytes in the retina) [44]. Since SPI-3 is expressed only under inflammatory 
conditions previous studies speculated that it might have protective effects against inflammatory 
damage [43, 45]. Many SPIs have been involved in potent protective activities such as wound-
healing [46]. SPI-3 may have similar anti-inflammatory properties under local inflammatory 
conditions. It has been shown that SPI-3 gene is strongly induced during the acute-phase reaction 
and it is regulated at the transcriptional level by interleukin 6 (IL-6) [42] and also by interferon 
gamma (IFNgamma) [47]. IL-6 and IFNgamma are cytokines with pleiotropic activities, each 
playing an important role in the host defence system. It was demonstrated that transcription factors 
such as STAT3 and STAT5B are involved in the induction of the SPI-3 promoter whereas 
C/EBPbeta reduced the transcriptional activity of the promoter [48]. Intestinal restitution induced by 
TFF3 is also associated with IL-6/Gp130/STAT signaling [49]. TFF3 activates STAT3 [50] that 
exerts anti-apoptotic and mitogenic effects [51]. Additionally, unpublished data suggest that optic 
nerve injury does not induce expression of SPI-3, whereas rat motor nerve transection dramatically 
induced SPI-3 expression in the injured motor neurons [44]. A human homolog of SPI-3, protein 
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inhibitor 6 (PI-6) was shown to inhibit cathepsin G which activates a proapoptotic protease, 
caspase-7 [52, 53]. This may suggests that SPI-3 may prevents caspase-7-mediated apoptosis, 
which is caused by damage such as nerve injury or inflammatory stimulation. Tff3 deficient mice 
showed increased sensitivity to intestinal damage with augmented apoptosis suggesting a 
protective role of Tff3. Tff3 prevents apoptosis after injuries in a range of cell lines, an effect that 
requires activation of both the epidermal growth factor (EGF) and phosphoinositide 3-kinase (PI3K) 
receptors [49]. Together these data suggest that up-regulation of serpina3n plays an important 
compensatory role when Tff3 protein is missing and may not act as a protector and anti-apoptotic 
factor. Further studies involving analysis of neurons and synapses of the IC of Tff3 knock-out mice 
may confirm this postulate. 
Presently there are no known patients with hearing impairment linked to both new candidate 
genes. SERPINA3 is localized on 14q32.1 and there is no known gene related to hearing nearby. 
PTTG1 is on 5q35.1. Somewhat in the vicinity, in 5q31, there are two genes, DIAPH1, POU4F3, 
and unknown genes for DFNA42 and DFNA54 but on the molecular genetic level this distance 
excludes SERPINA3 and PTTG1 as being involved at the present time. Therefore the expression 
changes observed in both proteins may be unrelated to hearing loss. However, loss of Pttg1 has 
been related to senescence in the pancreas and pituitary suggesting a general defect in various 
organs during ageing [54, 55]. In the case of serpina3n it is worthwhile mentioning that a member 
of the serpin gene family, SERPINB6 has recently been associated with hearing loss in human 
patients [56]. Therefore further studies directed at the function of Pttg1 and serpina3n in the Tff3 
knockout mouse model may provide important insights on the roles of these genes during the 
development of age-related hearing loss. 
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Figure 1: Average mouse audiograms at different ages for (A) wildtype and (B) Tff3 knockout 
animals. ABR-threshold curves were measured at the ages indicated in the legend. Threshold-loss 
was calculated relative to the average threshold of the wildtype mice at postnatal day 23. In 
wildtype mice a threshold loss was observed, increasing from low to high frequencies at any age.  In 
knockout-mice a conspicuous threshold loss in the low-frequency range was observed even in the 
youngest animals measured. With increasing ag  the high-frequency threshold loss increased. At 11 
and 15 months the difference between knockout and wildtype animals was significant at any 
frequency.  
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Figure 2: Immunohistochemistry showing expression of otoferlin (red) and neurofilament subunit 
200 (NF200, green) (A), potassium channel KCNQ4 (red) (B), prestin (C), potassium channel 
KCNJ10 (red) (D), and (E) synaptophysin (green) in 12 months old wild-type and Tff3 knock-out 
mice. Expression of all proteins was normal in Tff3 knock-out animals in comparison to wild-type 
mice. Nuclei are stained in blue with DAPI. Open arrows indicate outer hair cells (OHC), filled arrows 
indicate inner hair cells (IHC), filled arrowheads point out staining with the respective antibodies. 
Scale bars: A, B = 50 µm, C-E = 20 µm.  
99x190mm (300 x 300 DPI)  
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Figure 3: Immunohistochemistry showing expression of (A) Tff3 (red), (B) potassium channel 
KCNJ10 (red), (C) potassium channel KCNQ1 (red), and (D) megalin (green) in the stria vascularis 
(SV) of 12 months old wild-type and Tff3 knock-out mice. In Tff3 mutants and in wild-type mice in 
the presence of a Tff3 peptide no Tff3 expression was observed (A). Expression of KCNJ10, KCNQ1 
and megalin was normal in Tff3 knock-out animals in comparison to wild-type mice.. Nuclei are 
stained in blue with DAPI. Arrows indicate staining in the SV. Scale bars: left panels in A and B-D = 
50 µm, right panels in A = 20 µm.  
99x167mm (300 x 300 DPI)  
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Figure 4: Differential expression of securin (Pttg1) (A, B) and serpina3n (C, D) in adult Tff3 knock-
out versus wild-type animals. Results of quantitative RT-PCR (qRT-PCR) experiments performed 
with RNA samples isolated from the inferior colliculus (A, C), and cochlea (B, D) of wild-type (WT) 
and Tff3 knock-out (KO) animals. The level of expression in wild-type animals was arbitrarily set to 
1. Expression of Gapdh was used as control reference. Differences were tested by a two-tailed 
Student´s t-test: P<0.01.  
99x141mm (300 x 300 DPI)  
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Figure 5: (A) Securin expression in the organ of Corti (left panel) and in spiral ganglion neurons 
(right panel), shown for a 4-month-old Tff3 wild-type mouse. Filled arrowheads point at Deiter´s 
cells. Filled arrows indicate outer hair cells (OHC), open arrows indicate inner hair cells (IHC). Insets 
show images, where the primary antibody was omitted. (B) No securin expression could be detected 
in the spiral ganglion neurons of an age-matched Tff3-/- mouse. Scale bars: left panel in A = 50 
µm, right panel in A = 20 µm, B = 20 µm. (C) Semiquantification of the securin protein level in 
cochlear tissue of Tff3 wild-type and Tff3-/- mice at indicated ages was performed using Western 
blots. Ezrin was co-detected to confirm the loading of approximately equivalent amounts of protein. 
Securin protein is highly expressed in young animals (P22), both in wild-type as well as in knockout 
mice, although expression of securin protein in P22 Tff3-/- mice appears slightly reduced. In adult 
wild-type mice the level of securin protein in cochlear tissue is downregulated compared to P22. In 
12-months-old Tff3-/- mice, securin protein could not be detected at all. (D, E) Securin expression 
in the inferior colliculus, shown for a 9-month-old Tff3 wild-type (D) and an age-matched Tff3-/- 
mouse (E). Left panels show overview images and the right panels show a higher magnification. 
Securin protein is stained in brown (arrows). Inset shows an image, where the primary antibody 
was omitted. Note that securin expression in the inferior colliculus of an age-matched Tff3-/- mouse 
is strongly reduced compared to Tff3 wild-type. Scale bars: left panel in D, E  = 200 µm, right panel 
in D, E = 50 µm.  
192x91mm (300 x 300 DPI)  
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Table 1 
 
Gene Average Fold Change 
Mouse 
Genome 
Informatics 
(MGI) 
Retinitis pigmentosa GTPase regulator interacting 
protein 1 (Rpgrip1) -13.9 1932134 
Pituitary-transforming gene 1 (Pttg1, Securin) -10.5 1353578 
Prolactin (Prl) -7.8 97762 
Quaking (Qk) -5.7 97837 
Serine (or cysteine) peptidase inhibitor, clade A, 
member 3n (Serpine 3n) +42.8 105045 
Potassium inwardly-rectifying channel, subfamily J, 
member 9 (Kcnj9) +6.6 108007 
Adenylate cyclase-associated protein (Cap1) +6.2 88262 
Tumor necrosis factor receptor superfamily, 
member 12a (Tnfrsf12a) +3.5 1351484 
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